The kinetics of interferon induction by poly ICLC in humans.
A preliminary trial of the interferon (IFN) inducer polyriboinosinic acid-polyribocytidylic acid in poly-L-lysine and carboxymethylcellulose (poly ICLC) was conducted in patients with chronic progressive multiple sclerosis (MS). Because IFN induction in men is greater than in women, the kinetics of IFN induction were studied. As no significant differences were found in the serum half-life of IFN, sex-linked differences in IFN clearance or degradation are not likely to be responsible for the differences noted. Because fever was the major limiting side effect in MS patient, the relationship of fever to IFN levels was assessed. Changes in temperature were not related to changes in IFN levels, suggesting that fever might be blocked without reducing IFN levels.
Bever
C T
CT
Neuroimmunology Branch, NINCDS, Bethesda, MD.
McFarland
H F
HF
McFarlin
D E
DE
Levy
H B
HB
D002266:Carboxymethylcellulose Sodium / Q000494:pharmacology* / Q000031:analogs & derivatives; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007369:Interferon Inducers / Q000494:pharmacology*; D007372:Interferons / Q000097:blood*; D007700:Kinetics; D008297:Male; D008747:Methylcellulose / Q000031:analogs & derivatives*; D009103:Multiple Sclerosis / Q000097:blood / Q000628:therapy; D011070:Poly I-C / Q000494:pharmacology*; D011107:Polylysine / Q000494:pharmacology* / Q000031:analogs & derivatives
D007369:Interferon Inducers; D011107:Polylysine; C019531:poly ICLC; D008747:Methylcellulose; D007372:Interferons; D002266:Carboxymethylcellulose Sodium; D011070:Poly I-C; D006854:Hydrocortisone